Sleep Apnea in Women: Why OSA Can Be Missed

Bottom line: Women can have obstructive sleep apnea without fitting the familiar picture of a very loud, obviously sleepy male snorer. Recent reviews describe a broader symptom pattern in women, including insomnia, fatigue, mood symptoms and poor sleep quality, while newer polysomnography studies suggest respiratory events may be more concentrated in REM sleep. These patterns can raise suspicion, but they do not create a separate self-diagnostic rule for women. OSA still requires appropriate objective testing interpreted in clinical context.[1-5]

The classic OSA stereotype is too narrow

Obstructive sleep apnea (OSA) is repeated partial or complete upper-airway obstruction during sleep.

The public stereotype is familiar:

• loud snoring;
• witnessed breathing pauses;
• gasping;
• obesity; and
• obvious daytime sleepiness.

Those features are important, but they are not the only way OSA presents.

A 2026 review focused specifically on women concluded that OSA remains underdiagnosed in part because women may report a different mix of symptoms and because commonly used screening and severity frameworks do not capture every sex-specific pattern equally well.[1]

That does not mean women have a different disease.

It means the same disease can be expressed differently enough that a stereotype-based screening shortcut can miss people.

Women with OSA may report insomnia or fatigue instead of classic sleepiness

The 2026 review describes women with OSA as more likely to report symptoms such as:[1]

• daytime fatigue;
• insomnia symptoms;
• depression or anxiety symptoms; and
• poor subjective sleep quality.

A 2025 review on reproductive aging similarly notes that women with OSA may be less likely to present with loud snoring or observed apneas and more likely to report insomnia or mood-related complaints.[4]

These symptoms are clinically useful only as clues.

They are also common in many people who do not have OSA.

Fatigue can come from insufficient sleep, anemia, depression, medication effects, chronic illness, circadian mismatch or many other causes.

Insomnia can exist by itself or coexist with OSA.

See Sleep Apnea vs Insomnia for why the two conditions can overlap without being interchangeable.

Snoring still matters—but its absence does not rule OSA out

Loud habitual snoring remains a useful OSA clue.

But the absence of memorable snoring should not be treated as a negative diagnostic test.

Someone who sleeps alone may not know whether they snore or stop breathing.

Respiratory events can also be stage-dependent, position-dependent or less acoustically dramatic.

That is why Snoring vs Sleep Apnea separates a symptom from the diagnosis.

REM-predominant OSA may be especially relevant in women

One of the most interesting newer findings concerns REM sleep.

A 2026 population-based polysomnography study included 604 adults with OSA, including 209 women.[2]

Women showed a pattern in which the apnea-hypopnea index was descriptively higher during REM sleep than during non-REM sleep, while men had a more balanced distribution across stages.[2]

A separate 2026 hospital-based study of 1,632 patients also found sex differences in respiratory-event composition and oxygenation. Women showed a greater predominance of REM-related oxygen desaturation events in moderate and severe OSA.[3]

These findings reinforce an older observation: whole-night averages can hide where the respiratory burden is concentrated.

But they do not prove that every woman with OSA has REM-predominant disease.

The correct conclusion is narrower:

REM-specific respiratory data may add information that a single whole-night AHI can flatten.

Why a whole-night AHI can sometimes understate the pattern

The apnea-hypopnea index (AHI) is the average number of apneas and hypopneas per hour of sleep.

It is useful, but it is an average.

Imagine two people with the same whole-night AHI:

• one has respiratory events distributed fairly evenly across the night;
• the other has relatively quiet non-REM sleep but dense clusters of obstruction during REM.

The same summary number can describe two different stage patterns.

That is one reason the 2026 women-specific review argues for more attention to sex-specific polysomnographic features rather than relying only on standard severity categories.[1]

Menopause is a risk modifier, not an OSA diagnosis

OSA risk in women changes across reproductive aging.

The 2025 review on reproductive aging describes a marked increase in OSA risk after menopause and emphasizes that ovarian aging appears relevant beyond chronological age alone.[4]

Potential contributors include changes in:

• sex hormones;
• fat distribution;
• upper-airway physiology; and
• cardiometabolic risk.[1,4]

But menopause does not mean a person automatically has OSA.

It means the threshold for considering sleep-disordered breathing may reasonably become lower when symptoms or other risk factors are present.

See Menopause and Sleep for the broader differential, including hot flashes, insomnia, restless legs and sleep apnea.

OSA in younger women still exists

It would be a mistake to turn “risk rises after menopause” into “premenopausal women do not get OSA.”

The 2026 review discusses OSA across the female lifespan and notes clinically relevant associations in premenopausal women as well.[1]

Pregnancy also changes airway, fluid, hormonal and metabolic physiology.

That makes pregnancy-specific sleep-disordered breathing a separate clinical context rather than a reason to apply ordinary adult assumptions unchanged.

See Pregnancy & Postpartum Sleep for that life-stage framework.

Screening questionnaires can miss nonclassic presentations

Questionnaires such as STOP-BANG, the Berlin Questionnaire and the Epworth Sleepiness Scale can help organize risk.

They are not diagnostic tests.

The 2026 women-specific review highlights limitations in current screening tools when applied to female OSA phenotypes.[1]

This makes intuitive sense because a tool performs best when the features it weights heavily match the population being screened.

If a woman with OSA has severe fatigue, insomnia and fragmented sleep but little recognized snoring or classic daytime dozing, a male-derived symptom stereotype may generate less suspicion.

That does not invalidate screening questionnaires.

It means a low questionnaire score should not overrule a concerning clinical picture.

Can home sleep apnea testing miss OSA?

Home sleep apnea testing (HSAT) is useful for many adults with uncomplicated, clinically suspected OSA.

But it is not equivalent to full laboratory polysomnography.

The 2026 review argues that some sex-specific polysomnographic patterns in women may not be well captured by standard home-test severity indices.[1]

A 2025 adult OSA guideline similarly states that HSAT should not be used as a stand-alone rule-out test when suspicion remains and identifies polysomnography as the diagnostic reference standard, especially in more complex situations.[5]

There are several reasons a home study can understate disease:

• many devices estimate recording time rather than measuring actual sleep time;
• sleep stages, including REM, may not be directly measured;
• respiratory-effort-related arousals may be incompletely captured;
• mild or stage-specific disease can be diluted by whole-night averaging; and
• technical failure or poor signal quality can reduce confidence.

So a reassuring home-study number is most reassuring when the test quality is good and the clinical context fits.

A negative home test does not mean “nothing is wrong”

If symptoms are persistent and suspicion remains substantial, the next question is not necessarily “Which supplement should I try?”

It may be whether the original sleep test answered the right question.

That is especially relevant when there are features such as:

• witnessed apneas or gasping;
• difficult-to-control hypertension;
• major unexplained daytime sleepiness;
• recurrent morning headaches;
• persistent insomnia plus breathing-risk clues;
• substantial cardiometabolic risk; or
• a symptom pattern that changed after menopause.

The point is not to push everyone into a sleep laboratory.

It is to avoid treating one imperfect negative screen as absolute proof against OSA.

Women do not need a separate do-it-yourself diagnostic threshold

Sex differences in presentation do not justify inventing a separate consumer cutoff such as:

“An AHI of X means OSA in women but not men.”

The newer literature is more nuanced.

It argues that sex-specific physiology, symptoms, stage distribution and outcomes may add useful context to standard metrics.[1-4]

That is very different from saying ordinary diagnostic standards should be discarded.

A clinician can consider:

• whole-night AHI;
• REM-specific AHI;
• oxygenation;
• arousal burden;
• symptoms;
• comorbidities;
• sleep duration; and
• test limitations

without pretending one number has no value.

Fatigue is not the same as excessive daytime sleepiness

This distinction matters especially when discussing women with possible OSA.

Sleepiness means an increased tendency to fall asleep.

Fatigue is a broader feeling of low energy, exhaustion or reduced capacity.

Someone can have severe fatigue without falling asleep easily.

Someone else can have pathological sleepiness while describing themselves as merely “tired.”

See Daytime Sleepiness vs Fatigue for the symptom-level distinction.

If irresistible sleepiness persists despite adequate sleep opportunity and sleep-disordered breathing has been addressed, the differential expands further. See Hypersomnolence vs Insufficient Sleep.

What the evidence does not support

Current evidence does not justify claims that:

• women with OSA usually do not snore;
• insomnia in a woman means she probably has sleep apnea;
• menopause automatically causes OSA;
• all female OSA is REM-predominant;
• a low Epworth score rules OSA out;
• home sleep testing is useless in women;
• every negative home study requires laboratory polysomnography;
• women need a separate self-diagnostic AHI threshold; or
• sex-specific patterns make objective testing unnecessary.

A better decision framework

If OSA is a possibility in a woman:

1. Do not require the full stereotype. Snoring and witnessed apneas are useful, but fatigue, insomnia and poor sleep quality can coexist with OSA.
2. Look at life stage. Menopause and pregnancy can change risk and physiology.
3. Separate fatigue from true sleepiness. They overlap but are not identical symptoms.
4. Use screening tools as screens, not verdicts. A low score cannot erase stronger clinical evidence.
5. Interpret home testing in context. A technically adequate positive HSAT can be very useful; a negative or low-severity result may be less definitive when suspicion stays high.
6. Preserve stage-specific information when available. REM-related burden can matter even when a whole-night average looks less dramatic.
7. Keep diagnosis objective. Symptoms and sex-specific patterns guide suspicion; they do not replace testing.

Bottom line

The strongest recent message is not that women have a completely different form of sleep apnea.

It is that a male-centered picture of OSA can be too narrow.

Women may present with less stereotypical symptoms, reproductive aging changes risk, and respiratory events may be more concentrated in REM sleep. Screening and home-testing frameworks can therefore under-recognize some cases.[1-5]

The practical rule is simple:

Do not dismiss OSA because a woman does not look like the stereotype—but do not diagnose it from atypical symptoms alone either.

Related reading

• Snoring vs Sleep Apnea
• Sleep Apnea vs Insomnia
• Menopause and Sleep
• Pregnancy & Postpartum Sleep
• Daytime Sleepiness vs Fatigue
• Hypersomnolence vs Insufficient Sleep